CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- 4 Exercise or conversion Hindson Benjamin J. acquired 34,266 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 3,000 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 2,676 shares at an average $34.07 ($91,158)
- 4 Open-market sale Hindson Benjamin J. sold 2,361 shares at an average $34.07 ($80,434)
- 4 Open-market sale Chief Financial Officer sold 1,626 shares at an average $34.07 ($55,392)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Chief Financial Officer acquired 20,297 shares (grant or award)
- 4 Grant or award Hindson Benjamin J. acquired 33,828 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 95,839 shares (grant or award)
- 4 Exercise or conversion Director acquired 10,000 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 11,500 shares (option exercise)
- 4 Insider Changes in Ownership
- 4 Open-market sale Chief Executive Officer sold 2,715 shares at $35.19 ($95,544)
- 4 Open-market sale Chief Financial Officer sold 987 shares at $35.19 ($34,734)
- 4 Open-market sale Hindson Benjamin J. sold 1,292 shares at $35.19 ($45,467)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 2,120 shares (grant or award)
- 4 Grant or award Director acquired 2,120 shares (grant or award)
- 4 Grant or award Director acquired 2,120 shares (grant or award)
- 4 Grant or award Director acquired 2,120 shares (grant or award)
Page 8 of 21 · 410 filings